v3.25.2
Related party transactions (Tables) - Alps Life Science Inc [Member]
12 Months Ended
Mar. 31, 2025
IfrsStatementLineItems [Line Items]  
Schedule of consolidated financial statements the related party transactions

 

   2025   2024 
   USD   USD 
         
Associates:          
Alps Globemedics          
Agent commission   196,531    120,189 
Management fee income   13,534    12,916 
           
Related party:          
Director          
Agent commission   45,590    18,102 
Consultancy fee   -    51,663 
Patent License Agreement*   -    707,028 

 

*During the financial year ended 31 March 2024, the Company entered into a Patent License Agreement with a director of the Company, wherein the director shall grant to the Company an exclusive, royalty-free and non-transferable right and license all the patents stated in the agreement.
Schedule of key management personnel

 Schedule of key management personnel

   2025   2024 
   USD   USD 
         
Fee   79,988    71,811 
Salaries and other emoluments   185,871    162,726 
Defined contribution plans   20,555    19,255 
           
Total   286,414    253,792